• Profile
Close

Adjunctive eslicarbazepine acetate in pediatric patients with focal epilepsy: A systematic review and meta-analysis

CNS Drugs Evidence based | Mar 26, 2018

Lattanzi S, et al. - The efficacy and safety of eslicarbazepine acetate as an add-on treatment for focal-onset seizures were evaluated in pediatric patients using meta-analytical techniques. Findings suggested the potential of adjunctive eslicarbazepine acetate as an effective well-tolerated option in children and adolescents with focal-onset seizures uncontrolled by one or more concomitant anti-epileptic drugs.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay